Investor profile
Benjamin Bell
Venture capital, Venture debt & PhD, CFA - Biotech Investor at Catalio Capital Management
Benjamin Bell is a PhD, CFA - Biotech Investor at Catalio Capital Management, whose known portfolio counts 19 companies.
Is Benjamin Bell a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
- Focus
- BioinformaticsBiotechDiagnosticsDrug DiscoveryDrug Discovery PlatformGeneticsGenomicsLife ScienceMachine LearningTherapeutics
Contacts
Affiliated funds' portfolios
PhD, CFA - Biotech Investor at Catalio Capital Management, whose known portfolio counts 19 companies
- Parabilis Medicines
- Beacon Biosignals
- Noetik
- Imperative Care
- COMPASS Pathways
- Character Biosciences
- Medra AI
- Orasis Pharmaceuticals
- Aviceda Therapeutics
- DNA Script
- Imbria Pharmaceuticals
- Somethings
- and 7 more
Investor Profile
Founders in the listed sectors AI and Healthcare, and focus areas Bioinformatics, Biotech, Diagnostics and Drug Discovery fall inside that listing.
Stage-wise, the deals at Catalio Capital Management cluster around Growth, Late-Stage and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Benjamin Bell is worth approaching.
Colleagues at Catalio Capital Management
George Petrocheilos
Co-Founder & Managing Partner
New York, United States
Matthew J. Hobson
Principal
New York, United States
Jonathan Blankfein
Investor
New York, United States
R. Jacob Vogelstein
Co-Founder
Washington, United States
Will Denehy
Vice President
United Kingdom
Tom Brooks
General Partner
Baltimore, United States
John Henry Iucker
General Partner
New York, United States
Frequently asked questions
Who is Benjamin Bell?
Benjamin Bell is a venture capital investor and venture debt investor based in Baltimore, Maryland, United States, listed as PhD, CFA - Biotech Investor at Catalio Capital Management. The known portfolio of that firm counts 19 companies. That portfolio belongs to the firm, not to Benjamin Bell personally.
What does Benjamin Bell invest in?
Listed sectors include AI and Healthcare; listed focus areas include Bioinformatics, Biotech, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Benjamin Bell invest at?
Catalio Capital Management appears in Growth, Late-Stage and Seed rounds across its known deals, and Benjamin Bell is listed there as PhD, CFA - Biotech Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Benjamin Bell listed at?
Benjamin Bell is listed as PhD, CFA - Biotech Investor at Catalio Capital Management. 7 other people in the database share a firm with Benjamin Bell.
How do I contact Benjamin Bell?
An email address, a phone number and a LinkedIn page are on file for Benjamin Bell. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal